Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02510469 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03007446 | The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | unknown | Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT03271073 | A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 20 | Beijing Friendship HospitalOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03258034 | A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer | unknown | Phase 2 | 50 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT01406249 | XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01412294 | XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | unknown | Phase 2 | 40 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT03144843 | Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | unknown | Phase 2 | 110 | Sun Yat-sen UniversityOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03137004 | Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 47 | Fujian Cancer HospitalOTHER_GOV | 1 | May 8, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT02711033 | Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection | unknown | Phase 2 | 144 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT02779608 | The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT03016026 | Enhanced Recovery After Surgery (ERAS) on Laparoscopy-assisted Distal Gastrectomy | unknown | Phase 2 | 98 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02694081 | The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric | unknown | Phase 2 | 100 | Jilin UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT02976142 | The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer | unknown | Phase 2 | 150 | Moscow Clinical Scientific CenterOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT02617134 | CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT01504997 | Phase II Study for Robot Assisted Distal Gastrectomy(RADGphaseII) | unknown | Phase 2 | 23 | Shizuoka Cancer CenterOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer(NCT-B4) | unknown | Phase 2 | 40 | Jinling Hospital, ChinaOTHER | 1 | Oct 31, 2016 | clinicaltrials |
| NCT02873520 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02644148 | Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients | unknown | Phase 2 | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT02855788 | Metronomic Chemotherapy in Advanced Gastric Cancer | unknown | Phase 2 | 40 | Huashan HospitalOTHER | 2 | Aug 4, 2016 | clinicaltrials |
| NCT02529878 | Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02817425 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 300 | LanZhou UniversityOTHER | 1 | Jun 29, 2016 | clinicaltrials |
| NCT01100801 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients(3G) | unknown | Phase 2 | 90 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01227772 | Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 23 | National University Hospital, SingaporeOTHER | 3 | Jun 22, 2016 | clinicaltrials |
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | unknown | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02030561 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | unknown | Phase 1 / Phase 2 | 29 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02805829 | Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer | unknown | Phase 1 / Phase 2 | 20 | Xuzhou Medical UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01542294 | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer | unknown | Phase 1 / Phase 2 | 71 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT01739894 | Feasibility Study of Intraperitoneal Paclitaxel | unknown | Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT02317471 | Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 45 | Chinese PLA General HospitalOTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT02215837 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | unknown | Phase 2 | 40 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02572050 | Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection(AaRon) | unknown | Phase 2 | 87 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02388581 | First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL | unknown | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02662959 | Irinotecan as 3rd Line Therapy in Gastric Cancer | unknown | Phase 2 | 93 | Fudan UniversityOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02632201 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
| NCT01618474 | Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients | unknown | Phase 2 | 100 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02623153 | Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 | 200 | Tianshu LiuOTHER | 0 | Dec 7, 2015 | clinicaltrials |
| NCT02409199 | A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer | unknown | Phase 2 / Phase 3 | 66 | Shanghai Zhongshan HospitalOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01088204 | Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer(COACT_1001) | unknown | Phase 2 | 204 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02549911 | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis | unknown | Phase 2 | 40 | Zhejiang Cancer HospitalOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT02525237 | Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 30 | Qingdao Municipal HospitalOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02504229 | DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment | unknown | Phase 2 | 80 | Beijing Biohealthcare Biotechnology Co.,LtdINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00674167 | The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma | unknown | Phase 2 | 21 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2015 | clinicaltrials |
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | unknown | Phase 2 | 160 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT02413476 | Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy | unknown | Phase 2 / Phase 3 | 120 | wei boOTHER | 0 | May 19, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 9, 2017source: clinicaltrials